drugset / Trial / NCT02414048

Hypoxia Analysis in Head and/or Neck Cancer

NCT02414048

Phase 2 Unknown 10 enrolled Marius Gustav Bredell
NaSingle-groupOpen-labelDiagnostic

Summary

The primary objective is the prospective determination of disease-specific and overall survival in head and neck cancer patients who have undergone surgery, correlated to non-invasive methods of measuring tumour hypoxia. The secondary objective is to define tumour hypoxia using non-invasive methodology.

Timeline

Start
2015-04
Primary completion
2022-10
Completion
2022-10

Drugs

EvaluationDrugModalityDoseRoute
Subject Pimonidazole Diagnostic / imaging agent Oral

Indications